Cystic gene dosage influences kidney lesions after nephron reduction

Nephron
|December 23, 2014
PubMed

Insights

Acquired cystic kidney disease (ACKD) mechanisms were studied using a nephron reduction model. This model revealed increased cell proliferation and altered polycystin expression, suggesting gene dosage is crucial in ACKD development.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • Cystic kidney diseases involve progressive cyst development, often leading to renal failure.
  • Inherited polycystic kidney disease (PKD) mechanisms involve cell proliferation, apoptosis, and polarity defects.
  • Mechanisms underlying acquired cystic kidney diseases (ACKD) remain poorly understood.

Purpose of the Study:

  • To investigate the mechanisms of cyst development in acquired cystic kidney diseases (ACKD).
  • To utilize the nephron reduction model to study ACKD pathogenesis.
  • To explore the role of gene dosage in ACKD.

Main Methods:

  • Employed a nephron reduction model to induce and study acquired cystic kidney disease.
  • Analyzed morphological features, cell proliferation, apoptosis, and cell polarity markers.
  • Assessed the expression of key cystic genes, including polycystins, and evaluated the impact of Pkd1 haploinsufficiency.

Main Results:

  • Nephron reduction successfully recapitulated key morphological features of ACKD, characterized by tubular dilations.
  • Tubular dilation development was associated with significantly increased cell proliferation but not altered apico-basal polarity or cilia.
  • Marked increases in polycystin 1 and fibrocystin, with a decrease in polycystin 2, were observed; Pkd1 haploinsufficiency accelerated ACKD development and further increased cell proliferation.

Conclusions:

  • The nephron reduction model is suitable for studying acquired cystic kidney disease mechanisms.
  • Cell proliferation plays a critical role in ACKD development.
  • Gene dosage of PKD-related genes, such as Pkd1, is important in the pathogenesis of ACKD.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
639
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
339
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
327
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
656
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
567